Press Release PR9.NET
Home Submit Press Release Search Archives
Press Release
Advanced Search

Business Business
Associations, Trade
Business Services
Human Resources
Publishing & Printing
Marketing & Advertising
E-Commerce, Financial
Real Estate

Computers Computers
Entertainment Entertainment
Games Games
Health Health
Home Home
Science Science
Sports Sports
Society Society
Teens Teens
Press Release Category Business - Business Services - ValueNotes Database Release Date: March 26, 2008

Hiving off pharma R&D units - the key to lower risk and better valuation?

By ValueNotes Database
March 26, 2008
Send SEND Print PRINT Download PDF Version PDF Contact ValueNotes Database CONTACT

The Indian pharmaceutical industry is becoming competitive. In an attempt to reduce risk companies are planning strategies to hive off their R&D units. This is meant to focus on improved and innovative investment in R&D to achieve faster growth in the new chemical entity (NCE) business and value addition in the core generics business.

PR9.NET March 26, 2008 - Pune, India - As the industry becomes more and more competitive, Indian pharmaceutical companies are aggressively planning strategies to de-risk their business and are resorting to hiving off their R&D units. This is meant to reduce risk in the core generics business and to focus on improved and innovative investment in R&D, serving the dual purpose of achieving faster growth in the new chemical entity (NCE) business and value addition in the core generics business.

Dr. Reddy's Labs and Sun Pharma were the pioneers of this trend in the Indian market. Nicholas Piramal, Wockhardt and Ranbaxy are also planning similar moves in an attempt to reduce the risk in the parent company. The R&D firms can then focus on basic research and raise funds through PE funds, VCs or by way of an independent listing. This way, the interests of shareholders who may be risk-averse are protected, while options are provided to those with a larger risk appetite.

The fact that India has still not launched it first NCE has led many industry experts to be skeptical of the trend of hiving off R&D units. Some like Glenmark Pharma have hived off the generics business instead, and retained the R&D business, expecting better valuations for a generics business.

There are no clear-cut solutions, but Poonam Bhana, analyst at ValueNotes believes that hiving off R&D units is a judicious decision. It gives shareholders of the existing company an option to exit the risky R&D business while unlocking value of the R&D pipeline in the new company and also attracting investors that are prepared for a long wait before revenues flow in.

To minimize risk in the R&D companies, most firms are opting for collaborative R&D, for instance, Ranbaxy with GSK, Nicholas Piramal with Eli Lilly and Glenmark with Merck. Revenues in collaborative R&D business may flow in the form of royalty and/or milestone payments.

ValueNotes has published a report on Pharmaceutical Outsourcing in Drug Discovery and Development in April 2007. Subsequent updates have focused on key trends in the space such as partnerships and alliances, increasing role of bioinformatics in R&D, intergrated offerings of vendors.

ValueNotes Database
301, Venus Point, 1226/1 Off F.C. Road, Pune – 411004, INDIA
Tel: +91 20 66010423/24
Contact person: Arpita Bedekar

# # #

Contact Information of ValueNotes Database Contact Information of ValueNotes Database
Phone 91 20 6623 1717 / 1793
E-Mail E-mail Address Protected
Address ValueNotes Database Pvt Ltd
1, Bhuvaneshwar Society
Abhimanshree Road, Pashan
Pune 411 008, India

About ValueNotes Database

About ValueNotes

ValueNotes Database is a leading provider of business intelligence and research, with expertise across selected domains and types of customer needs. Working with clients across the globe, we have significant understanding of international markets.

The ValueNotes Outsourcing Practice is one of the largest information providers on the outsourcing industry. The Practice uses a comprehensive, analytical framework providing fresh insights into the fast emerging and yet, complex outsourcing space. We extensively track the space through regular analysis of news and events, continuous primary research and contact with the industry. Additional information is available at

ValueNotes Database Private Limited
1, Bhubaneshwar Society, Abhimanshree Road, Pashan, Pune 411 008
Contact: Nandita Harendra or Neeta Joshi
Tel: +91 20 6623 1700

Recent News Headlines
More Press Releases
Industry Category of Current Press Release
    Copyright © 2004 - 2014 PR9.NET - All rights reserved RSS Feeds Submit Press Release Terms of Service Privacy Policy